SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2022
Commission File Number: 001-41115
GENENTA SCIENCE S.P.A.
(Translation of registrant’s name into English)
Via Olgettina No. 58
20132 Milan, Italy
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
|Form 20-F ☒||Form 40-F ☐|
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
On May 10, 2022, the Company issued a notice announcing the date of its Ordinary and Extraordinary Meeting of its Shareholders. Materials relating to its upcoming virtual Ordinary and Extraordinary Meeting of Shareholders will be posted on its website on or about May 20, 2022.
|99.1||Notice of Call of Ordinary and Extraordinary Shareholders’ Meeting dated May 10, 2022.|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|GENENTA SCIENCE S.P.A.|
|By:||/s/ Richard B. Slansky|
|Name:||Richard B. Slansky|
|Title:||Chief Financial Officer|
Dated: May 11, 2022
Genenta Science S.p.A.
Registered office: Milan, via Olgettina n. 58
Subscribed and paid-up share capital of € 371,685.80
Tax code and registration number with the Milan Monza - Brianza Lodi Register of Companies: 08738490963
NOTICE OF CALL OF ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING
The shareholders of Genenta Science S.p.A. (the Company) are invited to participate in the ordinary and extraordinary shareholders’ meeting (the Shareholders’ Meeting) which will take place, in accordance with Article 9.5 of the Company’s Articles of Association (the Articles of Association), exclusively by teleconference, on 10 June 2022 at 2.30 pm, on first call, and if necessary, on 13 June 2022, at 5.30 pm, on second call, to resolve on the following
1. Approval of the financial statements for the year ended 31 December 2021.
2. Ratification of the appointment of Mark A. Sirgo as director and chairman of the Board of Directors.
1. Approval of the amendment to art. 15 of the articles of association in order to include the provision of the U.S. federal forum.
Information on the legitimacy to participate in the Shareholders’ Meeting and exercise of the right to vote as well as those concerning the methods of participation in the Shareholders’ Meeting are reported in the full notice of call, the text of which - together with the documentation relating to the Shareholders’ Meeting – will be available. on the Company’s website at www.genenta.com, as well as at the Company’s registered office in Milan, via Olgettina n. 58.
Milan, 10 May 2022
|The Deputy Chairman of the Board of Directors|